Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

9839	Companies
197510	Keywords
128581	Articles
105037	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 10/10/2024 at 07:06, 1 year 4 months ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
Heidelberg Pharma AG provides insights on its operational progress and financial figures for the first nine months of fiscal year 2024. Development activities, new clinical data, R&D webinars, and guidance updates are highlighted

Financial Figures Clinical Data Heidelberg Pharma AG R&D Webinars Guidance Updates
BRIEF

published on 10/01/2024 at 17:34, 1 year 4 months ago

Heidelberg Pharma Presents Promising Clinical Data for Lead ADC Candidate HDP-101

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC
BRIEF

published on 10/01/2024 at 17:34, 1 year 4 months ago

Heidelberg Pharma présente des données cliniques prometteuses pour le candidat ADC phare HDP-101

Heidelberg Pharma HDP-101 Myélome Multiple ADC Données Cliniques
PRESS RELEASE

published on 10/01/2024 at 17:29, 1 year 4 months ago

Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Heidelberg Pharma presents new clinical data on lead ADC candidate HDP-101 at IMS 2024, showing complete remission in one patient. Company developing innovative ADCs for cancer treatment

Clinical Data Heidelberg Pharma ADC IMS 2024 Complete Remission
BRIEF

published on 10/01/2024 at 15:32, 1 year 4 months ago

Heidelberg Pharma AG Announces Updated Financial Guidance

Financial Year 2024 Heidelberg Pharma Operating Expenses Updated Guidance Cash Requirements
BRIEF

published on 10/01/2024 at 15:32, 1 year 4 months ago

Heidelberg Pharma AG annonce une mise à jour de ses prévisions financières

Heidelberg Pharma Orientations Mises À Jour Dépenses D'exploitation Exercice Financier 2024 Besoins En Liquidités
PRESS RELEASE

published on 10/01/2024 at 15:27, 1 year 4 months ago

EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
Heidelberg Pharma AG adjusts its 2024 guidance, expecting sales and other income between EUR 10.0 - 12.0 million and operating expenses between EUR 30.0 - 33.0 million. The company anticipates secured financing until mid-2025

Financial Year Heidelberg Pharma AG Operating Expenses Updated Guidance Secured Financing
BRIEF

published on 09/23/2024 at 13:10, 1 year 4 months ago

Heidelberg Pharma to Present New Clinical Data on HDP-101 at IMS 2024

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma IMS 2024
BRIEF

published on 09/23/2024 at 13:10, 1 year 4 months ago

Heidelberg Pharma présentera de nouvelles données cliniques sur HDP-101 à l'IMS 2024

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques IMS 2024
PRESS RELEASE

published on 09/23/2024 at 13:05, 1 year 4 months ago

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
Heidelberg Pharma announces new clinical data on lead ATAC candidate HDP-101 to be presented at International Myeloma Society Annual Meeting 2024

Clinical Data Heidelberg Pharma HDP-101 ATAC Candidate Myeloma Society

Accesswire

Published on 02/10/2026 at 15:30, 1 hour 54 minutes ago

Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/10/2026 at 15:00, 2 hours 24 minutes ago

Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 15:00, 2 hours 24 minutes ago

Vox Royalty Releases Annual Investor Letter
Published on 02/10/2026 at 14:30, 2 hours 54 minutes ago

Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/10/2026 at 14:00, 3 hours 24 minutes ago

Horizon Aircraft Partners with North Aircraft Industries to Manufacture the Wings for the Cavorite X7

View all ACCESSWIRE

EQS Group

Published on 02/10/2026 at 16:35, 49 minutes ago

Michter's To Release Celebration Sour Mash, The Rarest Whiskey in the Distiller's Lineup
Published on 02/10/2026 at 16:15, 1 hour 9 minutes ago

Infinix to Deliver Industry-leading Performance with Snapdragon Platforms
Published on 02/10/2026 at 16:05, 1 hour 19 minutes ago

Brandwatch and Blackbird.AI Consortium Selected by NATO to Deliver Information Environment Assessment Capability
Published on 02/10/2026 at 15:30, 1 hour 54 minutes ago

Nebius announces agreement to acquire Tavily to add agentic search to its AI cloud platform
Published on 02/10/2026 at 15:15, 2 hours 9 minutes ago

Kasowitz and Mishcon de Reya Comment on Tirana Mayor Erion Veliaj's Year in Detention: For 365 Days and Counting, Mayor Veliaj Suffers Denials of Due Process Rights and Apparent Political Persecution

Les Echos

Published on 02/09/2026 at 18:00, 23 hours 24 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 23 hours 39 minutes ago

Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 23 hours 39 minutes ago

DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 23 hours 39 minutes ago

Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 23 hours 39 minutes ago

Déclaration des droits de vote à fin janvier 2026

View all LES ECHOS COMFI WIRE